Archives
-
Colistin–Gamithromycin Synergy in P. multocida
2026-08-31
This study integrated susceptibility testing, time-kill analysis, neutropenic-mouse efficacy, and pharmacokinetic–pharmacodynamic modeling to evaluate colistin plus gamithromycin against Pasteurella multocida. The combination was particularly effective against isolates with high colistin MICs, while exposure-based analysis supported substantially lower gamithromycin doses than monotherapy.
-
Lisinopril Dihydrate: Assay Logic Beyond ACE
2026-08-31
Lisinopril dihydrate is more than a long-acting ACE inhibitor: it is a useful perturbation tool for separating renin–angiotensin signaling from broader metallopeptidase effects. This guide connects biochemical selectivity, assay design, formulation, and cardiovascular and renal research decisions.
-
DiscoveryProbe Natural Product Library Plus: HTS Guide
2026-08-30
The DiscoveryProbe Natural Product Library Plus connects broad natural-product diversity with practical biochemical, cellular, and high-content screening workflows. Its pre-dissolved format helps researchers move from target-based hit discovery to orthogonal validation while reducing common handling and reproducibility problems.
-
Calpeptin: From Calpain Biology to Translation
2026-08-29
A translational framework for using Calpeptin to connect calpain biology with pulmonary fibrosis, inflammatory mediator control, and extracellular vesicle research.
-
Dual Tracing Finds No Postnatal Neo-Oogenesis
2026-08-28
Xie, Zhou, and Zheng use complementary Cre-loxP and Dre-rox lineage-tracing systems to test whether mouse ovaries generate new oocytes after birth. Across physiological aging and busulfan-induced ovarian injury, they detected no contribution of labeled non-germline cells to growing oocytes or metaphase II eggs, strengthening the case against in vivo postnatal neo-oogenesis.
-
Microfluidic Modeling of Gut Neuro-Epithelial Links
2026-08-28
de Hoyos-Vega and colleagues developed a two-compartment microfluidic device that separates intestinal epithelial and enteric neuronal cultures while preserving a defined interface between them. The platform enabled human organoid-derived epithelial cells and mouse myenteric neurons to form observable projections and contacts, providing a controlled model for studying gut sensory communication.
-
Sulfo-Cy5 carboxylic acid for Nano-Imaging
2026-08-27
Sulfo-Cy5 carboxylic acid is a water-compatible fluorescent dye for life sciences. This guide explains how its near-infrared properties can support rigorous nanoparticle tracking, release assays, and biological interpretation beyond simple signal detection.
-
How BHPF Inhibits GPER Signaling in Neuroblastoma
2026-08-27
A 2024 Environmental Science & Technology study identifies fluorene-9-bisphenol (BHPF) as a direct functional inhibitor of G protein-coupled estrogen receptor 1 (GPER/GPR30), rather than simply a nonspecific estrogenic contaminant. By combining molecular dynamics, receptor mutagenesis, gene knockout, calcium signaling, cytotoxicity, and transcriptional assays, the authors define receptor residues and signaling events that connect BHPF exposure with human neuroblastoma cell injury.
-
Phenytoin Workflows for Myelin Remodeling Research
2026-08-26
Phenytoin offers a controllable way to reduce voltage-gated sodium channel activity while pairing electrophysiology with live analysis of damaged myelin. This workflow translates evidence on reversible myelin swelling into practical assay design, fresh-solution handling, controls, and troubleshooting for neurological disease models.
-
KPT-330 (Selinexor): CRM1 Inhibition in Cancer Research
2026-08-26
KPT-330, also called Selinexor, is an orally bioavailable and selective CRM1/XPO1 inhibitor for preclinical cancer research. Its reported effects include inhibition of nuclear export, p21 retention, apoptosis induction, cell cycle arrest, and tumor growth inhibition in xenograft models.
-
Arrb2, 6-ketoLCA, and Hepatic IRI
2026-08-25
This study identifies a hepatocyte-to-macrophage signaling axis in which Arrb2 increases the bile acid metabolite 6-ketoLCA, promotes an anti-inflammatory M2 macrophage state, and reduces hepatic ischemia–reperfusion injury. Its combination of clinical samples, hepatocyte-specific mouse experiments, hypoxia–reoxygenation models, and metabolomics provides a mechanistic framework for studying immunometabolic control of liver injury.
-
Carbapenemase Gene Transmission in CREC, Guangdong
2026-08-25
Chen et al. integrate gene localization, antimicrobial susceptibility, conjugation, mobile-element profiling, and strain genotyping to characterize carbapenem-resistant Enterobacter cloacae across eight teaching hospitals in Guangdong. The study shows that blaNDM-1 is frequently plasmid-associated and transferable, linking multidrug resistance with both horizontal gene dissemination and clonal spread.
-
From ER Stress to Caspase-4 Translation
2026-08-24
Organelle-targeted peptide therapeutics are making cell-fate modulation more selective, but translational progress depends on measuring the pathways that actually execute inflammatory death. This thought-leadership article connects enzyme-instructed self-assembly and endoplasmic-reticulum stress with a testable caspase-4 activity workflow. It explains where the evidence is strong, where the biology remains hypothetical, and how the Caspase-4 Colorimetric Assay Kit can strengthen pyroptosis, inflammasome, and biomarker-development programs without overstating what a single readout can prove.
-
Gentamycin Sulfate for Resistance Research
2026-08-24
Use Gentamycin Sulfate as a controllable ribosomal stressor for bacterial protein synthesis research, resistance profiling, and Gram-negative infection models. This practical guide connects assay design with the large European non-fermenter susceptibility study while clearly separating validated observations from workflow recommendations.
-
Zoledronic Acid: From Assay Design to Mechanism
2026-08-23
Explore how Zoledronic Acid can be studied through mechanism-aware cancer and bone-disease assays. This guide translates a recent causal immunology framework into practical decisions for dose–time mapping, apoptosis validation, and evidence-limited cross-domain interpretation.